Dr. John B. Dever, MD

Dr. Dever practices at Boise Endoscopy Center in Boise, Idaho.

Dr. Dever's NPI, 1093918724, was assigned on June 8, 2007. Dr. Dever graduated from Saba University School of Medicine in 2006. Dr. Dever holds Idaho license M-16522.

Dr. Dever's primary practice is Boise Endoscopy Center, at 425 West Bannock Street, Boise, ID 83702. The practice phone is (208) 342-7169. Dr. Dever also practices at Boise Endoscopy Center, LLC, 1216 Garrity Blvd, Nampa, ID 83687.

Dr. Dever's primary practice is Boise Endoscopy Center in Boise, Idaho. Dr. Dever is also affiliated with St. Luke's Nampa Medical Center. The medical group on file is Idaho Gastroenterology Associates. Dmand AI also links Dr. Dever to 1 more hospital, 2 group practices and clinics, 2 medical groups and 1 ambulatory surgery center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Dever practices, 6 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Dever's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Dever is board certified in gastroenterology by the American Board of Internal Medicine. Dmand AI has Dr. Dever's licenses on file in 7 states: Idaho, California, Florida, Colorado, Massachusetts, Washington and Rhode Island.

Dmand AI lists acid reflux, chronic anemia, chronic inflammatory bowel disease (IBD), cirrhosis of the liver, gastrointestinal bleeding and irritable bowel syndrome (IBS) among the conditions Dr. Dever treats.

CMS data shows 407 Medicare services from Dr. Dever across 10 procedure codes in 2024, for 186 Medicare patients. Medicare paid $28,058 for them.

CMS counts 186 Medicare patients who saw Dr. Dever in 2024. The largest group is 65 to 74, with 92 patients. 75% of them have high cholesterol, and 73% have high blood pressure. 8% are also on Medicaid. Their average risk score is 1.32, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Dever's median patient age at 60, with 51% women.

In 2024, Dr. Dever wrote 396 Medicare Part D claims for 194 patients. 89% of them were for generic drugs. CMS names the drug for 322 of them, across 6 drugs with 11 or more claims each, at $21,550 in total drug cost. In 2023, CMS named 223 claims across 5 drugs.

Dr. Dever accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 388 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Dever, more than 97% of the clinicians it reports for that procedure.

Dmand AI links 11 papers to Dr. Dever, published from 2009 to 2017. 2009 was the busiest year, with 2. The most frequent topics are Bacterial Infections, Peritonitis and Anti-Bacterial Agents. Dr. Dever has published most often in Aliment Pharmacol Ther. Dr. Dever's most frequent co-authors are Muhammad Yasin Sheikh, MD, Stephen W. Bayles, MD and John J. Brandabur, MD.

CMS Open Payments shows 15 general payments to Dr. Dever from 9 drug and device companies from 2023 to 2025. Food and beverage make up the largest share, 100% of the total. Mauna Kea Technologies, Inc. paid the most, $97.

Dr. Dever graduated from Saba University School of Medicine in 2006.

Dr. Dever is in network with 8 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 6. Check the plan with the practice before a visit.